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PCOS Project
ABSTRACT
Polycystic Ovarian Syndrome: Proposal for an Evidence-based Management Plan for an
Electronic Patient Record System
Mary Elizabeth DuRant
The goal of this change project was to improve the diagnosis and management of women
with polycystic ovarian syndrome (PCOS) through the use of an electronic patient record system.
PCOS is one of the top ten missed or delayed diagnoses as well as an inconsistently or
mismanaged women’s health issue in primary care.
The chronic care model, known pathophysiology, and evidence-based research composed
the framework used in developing the diagnosis and management plan for an electronic record
system in a free health care clinic.
The project was evaluated based on the following four objectives: 1. To provide an
educational session at a free clinic to increase providers’ knowledge about diagnosing PCOS; 2.
To assess health care providers' knowledge about PCOS and its management before and after an
educational session; 3. To develop a management plan and imbed the plan in an electronic
patient record system at the free clinic to improve efficiency and quality of care for PCOS
management; 4. To evaluate the effectiveness of an electronic management plan in increasing the
frequency of diagnosis and appropriateness of treatment of PCOS at the free clinic. Objective
one was evaluated by testing providers’ knowledge before and after the educational session. Preand post educational session chart review was used to evaluate objectives two through four.
Thirty- four total charts met the inclusion criteria for evaluation for this project.
Analysis of the data revealed a significant improvement in knowledge level of providers
after the educational session. However, no statistically significant difference between pre and
post educational session was found in diagnosing and managing the metabolic status of the
PCOS population at the clinic.
This project is an initial step in utilizing technology to improve diagnosis and
management of a frequently misdiagnosed or under diagnosed and mismanaged common chronic
syndrome on women.
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PCOS Project 1
Polycystic Ovarian Syndrome: Proposal for an Evidence-based Management Plan for an
Electronic Patient Record System
Background and Significance
Polycystic ovarian syndrome (PCOS), the most common endocrine disease of women of
reproductive age, affects 5 % to 10% of women, causing lifelong ramifications which affect
women‟s health (Dunaif, Givens, Haseltine, & Merriam, 1992; Hart, Hickey, & Franks, 2004).
Despite PCOS being a common health problem in women, it is frequently under diagnosed and
inconsistently managed (Tomlinson, & Pinkney, 2007). It is one of the top ten missed diagnoses
in primary care. Multiple reasons contribute to this syndrome being difficult to diagnose during
its early manifestation. The leading factors that contribute to missing a diagnosis by a provider
include: failures in judgment (79%); vigilance or memory (59%); knowledge deficit (48%); and
patient-related factors (46%) such as atypical clinical presentation (15%), and complicated
medical history (10%) (Gandhi, et al., 2006).
In the case of PCOS, many reasons contribute an initial missed diagnosis by the health
care provider. PCOS is a group of symptoms, signs, and biochemical features that occur in
various combinations and with varying degrees of severity (Elghblawi, 2007). The predominant
symptoms of PCOS, such as hirsutism and irregular or absent menstrual cycles, can be present
due to other causes. The heterogeneous nature of this endocrine disorder causes women to
present to various health care settings for help. With resolution of the problem, the patient may
not return for further evaluation to determine the underlying cause of the initial problem. The
inconsistencies in the investigation and management of PCOS compound this problem of failure
to diagnose.
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PCOS is a chronic endocrine disorder that has a major impact on the reproductive,
metabolic, and cardiovascular health of affected women. Women with PCOS are at risk for
developing type 2 diabetes mellitus, hyperlipidemia, endometrial cancer, and infertility problems
(Ehrmann, 2005; Guzick, 2004; Sherif, 2006; Taylor, 1998). Providers in a free clinic in a West
Virginia (WV) community which serves uninsured lower income people treat a population of
women from 18 to 65 years of age. This clinic is the only access to primary health care these
patients. The clinic is staffed by a variety of physicians and advanced practice nurse practitioners
who volunteer their time or receive a small compensation for their services. Thus, providers from
various specialties staff this clinic. It is therefore essential to educate primary care providers from
differing health care specialties, nurses and other health care professionals about the criteria used
to establish a diagnosis of PCOS in female patients. These practitioners must learn to initiate a
management plan to prevent or minimize the complications and consequences of the disease.
Scope of the Problem Related to PCOS; Necessary Knowledge Base for Health Care Providers
PCOS is a complex syndrome that does not present with a consistent set of symptoms.
The sum of the whole syndrome causes greater morbidity than the complications from each
individual symptom. The genetic component and the presentation of menstrual irregularities in
adolescence may cause both the adolescent and the health care provider to assume these
symptoms are normal because they have occurred in other women in the family and irregular
menses is common in early puberty (Meisler, 2002).
Ideally, the diagnosis of PCOS should be suspected in childhood, and suspected if other
women in the family have PCOS or have obesity with type 2 diabetes mellitus. Irregular
menstrual cycles may be the first presenting symptom to suggest the existence of PCOS. Care in
pediatrics, family medicine, or gynecology is often sought initially for help in regulating
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menstrual cycles or in early adulthood to treat infertility. Oligo-ovulation manifests as menstrual
irregularity and occurs in 70% of women with PCOS. Women with PCOS often report irregular
menstrual patterns, and experience varying degrees of ovulatory dysfunction. Often the
menstrual pattern (i.e., three to five days of menstrual flow every 28 to 35 days) occurs for the
first one to two years after menarche (which occurs at the normal age), but menses then become
less frequent, occurring every 45 to 365 days (Richardson, 2003). After the onset of puberty,
75% of women with secondary amenorrhea meet the diagnostic criteria for PCOS (Azziz, et al,
2006; Hill, 2003; King, 2007). This is why the diagnosis tends to be made post-puberty.
Women enter the health care system seeking care for the individual symptoms causing a
problem. Because there is a wide range of problems which result from PCOS, young teens and
women enter the health care system seeking care from practitioners from many health care
disciplines. Women often seek the care of the practitioner who they feel is appropriate to manage
the immediate problem. Thus the immediate diagnosis, such as irregular menses, diabetes, or
acne may be treated, but the diagnosis of PCOS may be delayed (Birnbaum, 2003).
Hyperandrogenemia is present in 60% to 80% of women with PCOS (Azziz, et al, 2006).
Elevated androgens cause hirsutism in 60% of sufferers, acne in 15% to 25%, and androgenic
alopecia in an estimated 5% of women with PCOS (Azziz, et al.). The diagnosis may be made
when women begin seeking help with dermatological or hair removal problems (Salmi, Zisser, &
Jovanovic, 2004).
Qualitative studies report phenotypic characteristics of PCOS affect quality of life and
self esteem for these women. In Snyder‟s study (2006), women with PCOS recognized
themselves as different from other women without the disease, as the syndrome manifests with
varying symptoms. Higher than average weight gain, lack of regular menstrual cycles, very
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heavy or continuous bleeding with occasional menses, growth of excessive unwanted facial and
body hair, and severe mood swings were identified as the characteristics that made PCOS
sufferers feel different. Patients with PCOS also expressed that feeling different created a sense
of insecurity and isolation (Snyder). Obesity also contributed to a sense of being not normal or
not looking like the media portrayal of femininity (Snyder). Women with PCOS identify that
being a normal female means looking more female (without hirsutism), having a beautiful
complexion, and having regular menstrual cycles (Snyder). They recognized that hirsutism and
infertility problems made them feel less feminine as though womanhood had been stolen
(Kitzinger & Wilmot, 2002; Snyder). The physical signs of PCOS can be detrimental to a teenage
girl‟s self-image. Early diagnosis and treatment in adolescents are essential in ensuring health in
adulthood and restoring self-esteem (Salmi, et al., 2004).
The health care system does not have a niche into which PCOS fits. An e-mail
correspondence with the medical director of the Center of Excellence in Women‟s Health
(CoEWH) at a large eastern health science center also supports the patient perceived need for this
project. The e-mail is as follows, “One of my patients recently pointed out that it is a disease
without a home after she had been put off by several providers who did not feel competent to
address it.” (Davisson, personal communication, March 19, 2008). In personal discussions with
this author, three young women under 22 years of age stated that in their experiences, none of
their health care providers had ever explained what PCOS is or the range of potential health
problems it causes, nor did these providers discuss how PCOS could affect their lives.
Diagnosing and Treating Chronic Illness
Almost half the population of Americans, 133 million people, lives with a chronic
condition (Partnership for Solutions, 2004). A chronic health care condition is any condition that
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requires management by the affected person and interface with a health care system. For the best
outcome for patients suffering with a chronic disease, the management plan should involve both
the provider and the patient in actively managing the disease (Wagner, Austin, & Von Korff,
1996a, 1996b). PCOS is a chronic health care condition that should be managed daily by the
patient with support from health care providers. The management plan needs to focus on
obtaining and maintaining an optimum state of health (Wagner, et al., 1996a)
Traditional primary care systems are not designed to meet all the needs of a patient with a
chronic illness. Problems in a traditional primary care system affecting the quality of care for
patients with chronic illness include: 1) rushed practitioners either not aware or not following
established care guidelines, 2) lack of care coordination due to the number of providers working
in a given care site, 3) lack of active patient follow-up, and 4) patients not appropriately trained
to manage their illness at home (Wagner, et al., 1996a, 1996b).
Many primary care systems focus on treating episodic or acute occurrences of illness.
The system, itself, reacts to delivering the care being requested by an ill person seeking care. The
free health care clinic in WV in which this project is based operates in this reactive mode. One
reason this occurs is because the clinic is staffed by clinicians who donate small amounts of their
time. Only mid-level providers staff the clinic full time. With this pattern of staffing, continuity
and coordination of care are often compromised. Patient‟s return or follow-up visits are often
with a different provider than was the initial visit. These factors tend to support a traditional
reactive approach to care. While PCOS is a common endocrine disorder in women, it is not one
of the problems commonly expected to present to primary care clinics. This fact and the varied
expertise of health care providers in the clinic may contribute to initially missing the diagnosis of
PCOS and less than ideal care being initiated (Gandhi, et al., 2006).
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In a systematic review of the literature, Azziz, et al. (2005) estimated approximately 4
million women in the United States (U.S.) have PCOS. When comparing percentages of women
with PCOS by region of the country, the greatest percentage, 34.72%, live in the Southern region
of the U. S., which includes West Virginia (Health Care and Utilization [HCUP], 2005). The
2005 census reports 352,442 women of reproductive age, between the ages of 18 and 44, are
living in W.V. (U.S. Census Bureau, 2006). Because 5% to 10% of women of reproductive age
suffer from PCOS, one can estimate that 17,622 to 35,244 women in this state are living with
PCOS.
Theoretical Framework
In an effort to address the health problems encountered in traditional primary care,
Wagner (1998) developed a Chronic Care Model (CCM). This model focuses on primary health
care system changes that are better able to manage patients with chronic conditions (Wagner).
These system changes include a nontraditional care approach for the provider, staff, and patient.
Studies reporting improvement in outcomes for various chronic illnesses support the
choice to use CCM to guide the development of this project. Bodenheimer, Wagner, and
Grumbach (2002a) performed a systematic review of studies of diabetes care programs that
included the CCM. They used the studies completed by the Cochrane review of ambulatory care
diabetic management programs as the basis for their review. The evidence demonstrates that the
CCM can improve the management of chronic conditions and reduce health care costs. Thirtytwo of 39 studies found that interventions based on successful management of chronic illnesses
are CCM model components that improved at least one process or outcome measure such as
hemoglobin A1C for diabetic patients. Eighteen of 27 studies discussing congestive heart failure,
asthma, and diabetes demonstrated reduced costs or lower use of health care services to manage
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disease (Bodenheimer, et al., 2002a). A study that exemplifies the effective use of CCM is a
randomized control trial performed in Denmark that focuses on primary care disease
management for diabetics (Zoffman, Harder, & Kirkevold, 2008). Patients were randomized to a
usual care group, or to an intervention group that provided decision support, regular follow-up,
reminder systems, and self-management support based on individualized goals. After six years,
the intervention group had significantly lower hemoglobin A1C, blood pressure and cholesterol
levels. This outcome supports the premise that use of the CCM is effective in primary care for
managing patients with chronic diseases. Other studies adopting CCM as the approach to treat
chronic illnesses such as cardiovascular disease, congestive heart failure, chronic obstructive
pulmonary disease, and depression report better patient outcomes than traditional models
(Adams, et al., 2007; Feifer, Ornstein, Nietert, & Jenkins, 2001; Stroebel, et al., 2005). A pilot
study by Stroebel et al. found the CCM was a useful guide for structuring the delivery of
effective chronic disease management for patients receiving care at a free clinic.
PCOS is a life-long condition with long-term complications. CCM offers a structure
under which chronic conditions are managed successfully using a prevention- based approach as
opposed to the traditional system that focuses on addressing acute care issues as they arise
(Bodenheimer, Wagner, & Grumbach, 2002b). These studies identify that use of the CCM to
develop a strategy for managing a chronic syndrome such as PCOS can be successful. This
proposed project, dubbed “The PCOS Project”, will be based on the elements of CCM.
Patients living with a chronic illness require different types of interaction and have
different needs from a health care system than can be met in an acute care focused primary care
system. The chronic care model was designed by the MacColl Institute for Healthcare Innovation
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to reshape primary care systems to better meet the health care needs of those living with a
chronic illness (Wagner, 1998).

The model is based on the successful interaction of an informed, activated, and
empowered patient having productive interactions with a prepared proactive team. An informed
activated patient is defined as a patient who seeks knowledge, is actively involved in self care,
and is an active participant in the decision making about his or her own care with the health care
providers. The model identifies six elements that are essential to bring about the productive
interactions between the provider team and the activated patient in order to improve outcomes.
These elements are also essential to creating the informed activated patient and the prepared
proactive team. The elements are: community involvement, health system leadership support,
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self-management support, delivery system redesign, decision support, and clinical information
systems (McCulloch, Price, Hindmarsh, & Wagner, 1998; Von Korff, Gruman, Schaefer, Curry,
& Wagner, 1997; Wagner, et al., 1996a; Wagner, et al. 1966b). When the six elements occur in
the clinical setting, the result is improved patient outcomes for patients living with a chronic
illness.
Literature Review
Chronic Care Model
More than half of patients with a chronic illness have multiple health problems that
require attention at each health care visit. As the number of patients with a chronic illness
diagnosis increased, Wagner, et al. (1996a) developed the CCM to correct the deficiencies of
usual care systems to meet this group of patients‟ needs. The CCM is a set of concepts that focus
on the infrastructure of ambulatory care systems to improve health care response to the needs of
patients with a chronic illness. The concept of the model is to change from a reactive to a
planned and proactive approach to managing chronic illnesses. CCM describes a reconfiguration
of the ambulatory health cares system that shifts from acute episodic visits to planned, routinely
scheduled visits that focus on function and prevention of exacerbations and complications
(Wagner, 1998).
The CCM model identifies elements of the health care system that lead to improved
outcomes for individuals with a chronic illness. The six essential elements of the CCM are: the
community, the health system, self-management support, delivery system design decision
support, and clinical information systems. The community element encourages the use of
community resources to meet the needs of patients and eliminates duplication of available
services. The health system element focuses on creating a culture and organization of care that
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promotes safe quality care. Self-management support places emphasis on the patient‟s role in
managing his/her health through empowerment and education (Bodenheimer, 2005; Von Korff,
Gruman, Schaefer, Curry & Wagner, 1997). Delivery system design assures the delivery of
effective, efficient, clinical care and self-management support (Wagner, et al., 1996b). Decision
support promotes clinical care that is consistent with evidence-based information and patient
preferences (Wagner, et al., 1996b). Clinical information systems organize both patient and
population information to facilitate efficient and effective care (Wagner, 1995). The combination
of these elements improves satisfaction and health outcomes of patients with chronic illnesses.
The Robert Wood Johnson Foundation authorized an independent evaluation of the CCM
process for those health systems adopting the model. The evaluation team included members of
the RAND Corporation (1999) and researchers from the University of California at Berkeley.
This team evaluated 51 participating sites involving approximately 4000 patients with diabetes,
congestive heart failure, asthma, and depression. The evaluation identified improvement in the
element areas of the model. Patients with diabetes had a significant decrease in cardiovascular
disease risks. Congestive heart failure patients were more knowledgeable, more frequently
stayed on recommended therapy, and had 35% fewer hospital days. Patients with asthma and
diabetes were more likely to receive appropriate therapy. Details of these findings are available
through the RAND „Health Program Improving Chronic Illness Care Evaluation‟. As PCOS is a
chronic health condition, improvement in patient health outcomes and satisfaction with the
health care system would be expected after application of CCM.
Missed or Delayed Diagnosis
A limited number of studies exist that address the effect of continuing health care
education in preventing missed or delayed diagnoses. Most studies address specific diagnoses
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and not the topic of continuing education and changes in diagnosis or disease management
changes. The following studies were found to support continuing education and practice changes
that improve diagnosis and care.
Gandhi, et al (2006) conducted a retrospective review of 307 closed malpractice claims in
which the alleged error was a missed or delayed diagnosis in the ambulatory setting. The purpose
of the review was to develop a framework for investigating missed and delayed diagnoses,
advance understanding of the cause, and identify opportunities for prevention.
The most common errors (85%) occurred in a physician‟s office, and the primary care physician
was the provider most commonly involved.
The predominant reason found for a missed diagnosis was failure to order an appropriate
diagnostic test followed by a failure to create a proper follow-up plan. Lack of knowledge of
appropriate testing was the most common reason given for failure to order a diagnostic test.
Other common errors causing a missed diagnosis in non cancerous diseases were delays by
patients in seeking care, taking an inadequate history or physical exam, and failure to refer
(Gandhi et al, 2006; Singh, Thomas, Myrna, & Peterson, 2007).
The factors attributed to a missed or delayed diagnosis were failures in judgment,
decrease in vigilance or memory, lack of knowledge, patient-related factors, and not performing
a physical exam. Although the study examined multiple, significant causes of breakdown in
either the system or the diagnostic process, human error was present as well. The human errors
identified were reliance on the physician‟s knowledge or memory to ensure the correct test is
ordered and poor communication strategies in the clinic setting. A patient-related factor of having
complex disorders was also a reason associated with delayed or missed diagnosis (Gandhi et al,
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2006). The conclusion of a study by Guradini, Talamini, Fiorillo, Lirutti, and Palese (2008) was
knowledge is progressively lost if refresher courses are not held on a regular basis.
Recommendations from Gandhi, et al. (2006) include changing the systems to alleviate
the cognitive errors by reducing dependence on memory for appropriate testing and clinical
diagnosis. Errors associated with follow-up and further evaluation can be decreased by forcing
consideration of evidence-based diagnostic plans or second opinions. Gandhi et al (2006) also
noted that for changes to have a maximum effect they must be easy to use and easily integrated
into the workflow. For example incorporating clinical decision-making support, appropriate
testing for diagnosis and appropriate follow-up in an electronic medical record will decrease
missed or delayed diagnoses.
Davis, Thomson, Oxman, and Haynes (1995) conducted a systematic review of studies
on education strategies and interventions that assessed physician performance and health care
outcomes. For this study, educational intervention was defined as any attempt to persuade
physicians to modify their practice performance. Three quarters of the studies reviewed (n=75)
were conducted in outpatient settings. They found that a physician reminder was an effective
single-method intervention to yield an effective practice change. Other studies found that success
in changing performance included reinforcing methods such as feedback or reminders. Barriers
to change included: individual readiness to change, decreased motivation to change, a knowledge
problem, or no perception of a gap between current knowledge and skills and knowledge needed
to bring about the practice change. Knowledge deficit and memory loss over time are significant
contributors causing missed or delayed diagnosis. Continuing education sessions or refresher
sessions are one way to change the incidence of a missed or delayed diagnosis. Reminder
systems such as electronic records that prompt reminders for providers are a way to positively
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effect change in both diagnosis and management of patients. Based upon the findings of these
studies an educational update and use of electronic prompt system should improve diagnosis and
consistency in management of PCOS.
Definitions of PCOS
Several definitions of PCOS have been proposed in an effort to encompass women with a
range of mild to more severe symptoms. In 1990, the National Institute of Child Health and
Development (NCIHD) convened a consensus conference to define the diagnostic criteria for
PCOS. Despite variability in opinions, the diagnostic criteria arising from the NIH conference,
include women who have both chronic anovulation and evidence of androgen excess for which
there is no other cause (Guzick, 2004).
The European Society for Reproduction and Embryology and the American Society for
Reproductive Medicine (Rotterdam consensus group) held an international consensus meeting in
Rotterdam, Netherlands in 2003. The goal of this group was to create diagnostic criteria to define
and diagnose PCOS. Although total agreement was not reached, the consensus of the Rotterdam
group defined the diagnostic criteria as a woman who has at least two of the following three
features present: (1) oligomenorrhea/amenorrhea, (2) clinical or biochemical signs of androgen
excess, and (3) polycystic ovary by ultrasound scan, for which there are no other causes
(Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004). Use of the
Rotterdam criteria incorporates many women with PCOS who would have been missed by
NCIHD criteria, thus increasing the prevalence to nearer 10%.
In an attempt to resolve the differences between the two accepted definitions, the
Androgen Excess Society (AES) task force performed a systematic review of medical literature
to compose a judicious definition of PCOS (Azziz, et al., 2006). They concluded that the
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original 1990 NCIHD criteria should be accepted as the definition of PCOS with some
modifications. Taking into consideration the opinion from the Rotterdam group, the AES task
force identified nine different phenotypes that could be could be used as criteria in diagnosing
PCOS based on the current knowledge. The nine phenotypes are: 1) hyperandrogenemia, 2)
hirsutism, 3) oligoanovulation, 4) polycystic ovaries, 5) combination of chronic anovulation and
androgen excess, 6) combination of oligomenorrhea/amenorrhea, clinical or biochemical signs of
androgen excess and polycystic ovary by ultrasound scan, 7) oligomenorrhea/amenorrhea, 8)
impaired glucose tolerance/insulin resistance, and 9) metabolic syndrome (Azziz, et al.)
AES defines PCOS as a disorder of androgen excess with an ovarian etiology and/or
consequences after exclusion of other known androgen disorders (Azziz, et al.). The absence of
clinical or biochemical indicators of excess androgen in women under the age of 40 with other
PCOS phenotypes makes the diagnosis of PCOS less certain (Azziz, et al.). Thus, three accepted
definitions of PCOS exist in health care (Azziz, et al., 2006; Guzick, 2004; The Rotterdam
ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004).
Etiology and Pathophysiology of PCOS
PCOS is the most common endocrine disorder of women, yet the etiology and
pathophysiology remain unknown. Defects in the reproductive endocrine pathways create a cycle
of abnormal hormonal secretions that cause the range of observed phenotypes. Many theories
have been proposed. They include 1) a complex genetic defect, 2) a defect in insulin action and
secretion causing insulin resistance and hyperinsulinemia, 3) a defect of androgen synthesis that
leads to enhanced ovarian androgen production, or 4) a neuroendocrine defect causing an
exaggerated lutenizing hormone (LH) pulse and frequency, causing excess adrenal androgen
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production (Tsilchorozidou, Overton & Conway, 2004). Each of the theories is based on what the
theorist identifies as the primary defect causing the self-perpetuating cycle of abnormalities.
The etiology is not clearly understood but studies suggest a genetic (autosomal-dominant)
component. PCOS is found predominantly in families. Studies attempting to define the specific
genetic cause suggest that PCOS is a complex multigenic disorder. The clinical and biochemical
presentation is influenced by environmental factors as well (Abbott, Dumesic & Franks, 2002;
Diamanti-Kandarakis & Piperi, 2005). Based on animal studies, Abbott, et al. suggests that
PCOS is a linear process that begins in utero. They postulate that either or both hyperandrogenic
fetal ovaries or the hyperandrogenic adrenal cortex are the cause of excess fetal androgen
production beginning in the second trimester. Androgens are potent gene transcription factors
and induce other critical transcription factors effecting gene expression. This implies fetal
androgen excess in female fetuses may reprogram coding in multiple organ systems that will
later appear as the varying phenotypes of PCOS (Abbott, et al.). Though not proven, there is
evidence to support the idea that a genetic defect causes the fetal ovary theca cells to over
produce androgens causing the cascade of changes in utero that lead to the syndrome (Urbanek,
et al., 2006).
The cause of insulin resistance (IR) and hyperinsulinemia remain uncertain.
Abnormalities in post-insulin signaling and abnormal insulin secretion have been identified in
women with PCOS. The insulin-signaling defect in adipocytes and skeletal muscle is specific to
PCOS. IR in PCOS occurs by a different mechanism than in women who are obese or have type
2 diabetes mellitus without PCOS (Corbould, Zhao, Mirzoeva, Aird & Dunaif, 2006). Androgens
are believed to contribute to peripheral insulin resistance in PCOS by acting directly on the
insulin-signaling pathways (Diamanti-Kandarakis, 2008).
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Sixty to 80% of women with PCOS have hyperandrogenemia (Diamanti-Kandarakis,
Papiliou & Palimeri, 2006). The over production of androgens by theca cells is a response to
increased stimulation of the ovary by LH. Theca cells in women with PCOS more efficiently
convert androgenic precursors to testosterone than do normal theca cells (Ehrmann, 2005).
Follicle-stimulating hormone (FSH) is responsible for regulating aromatase activity of the
granulosa cells. The level of FSH determines the amount of estrogen that is made from androgen
precursors (Ehrmann). FSH levels are often decreased in PCOS (Ehrmann; Marrinan, & Stein,
2007).
Insulin is both a direct and indirect contributor to hyperandrogenemia. It acts
synergistically with LH to enhance theca cell androgen production. Hepatic synthesis of sex
hormone-binding globulin (SHBG) is inhibited by insulin. Elevated levels of insulin decrease
SHBG so it is not available to bind with testosterone, thus increasing circulating levels of free
testosterone (Ehrmann, 2005). The increased androgens also inhibit the production of SHBG
(Marrinan, 2007). Elevations of free testosterone cause worsening clinical signs of
hyperandrogenism. Higher androgen levels contribute to central/android obesity, which increases
insulin resistance and worsening PCOS symptoms (Azziz, et al., 2005; Ehrmann).
Normal menstrual cycles occur when the hormone levels and feedback pathways of the
hypothalamic-pituitary-ovarian axis function appropriately. In PCOS, the hypothalamicpituitary-ovarian axis is disturbed. The defect that causes this disturbance is unknown. There is
thought to be an abnormality of the gonadotrophin-releasing hormone pulse generator of the
hypothalamus. It is unclear if this defect is primary or secondary (Marx & Mehta, 2003).
Elevated LH levels and normal or decreased FSH are found in PCOS. Also, increased levels of
free estrogen, primarily in the form of estrone and estradiol are found. Elevated estrogens cause a
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feedback effect on the pituitary that leads to further suppression of FSH and increased frequency
and amplitude of pulsating release of LH. This hormonal environment increases the production
and release of androgen precursors by theca cells. These androgen precursors are converted
peripherally to primarily estrone, which in turn enhances the feedback to the pituitary
perpetuating the cycle of elevated LH, decreased FSH, and increased androgen production
culminating in abnormal menstrual cycles and hyperandrogenemia (Ehrmann, 2005; Marrinan &
Stein, 2007).
Clinical Consequences of PCOS Pathophysiology
Early detection of health status changes is an important part of the prevention plan.
Prevention or delay of progression of PCOS involves ongoing secondary prevention aimed at
early disease detection, thereby increasing opportunities for interventions to prevent progression
of the disease and emergence of symptoms. Prompting providers to order recommended
surveillance screenings is built into HealtheWV charting program. Electronic patient record
systems that alert providers when recommended screening tests are due are important for
increasing consistency in managing a chronic illness and improving patient outcome. Potential
sequelae resulting from pathophysiology are included in both the educational offering and in the
electronic chart generated plan. The consequences of PCOS are the foundation for the
development of the program template. Each potential health threat from PCOS is described in
the following sections of the paper, as it will be incorporated into the educational program and
into the electronic charting program template.
Endocrine and Gynecological
Thirty to 40% of women with PCOS have impaired glucose tolerance. Type 2 diabetes
mellitus will develop in 10 to 45% of women with PCOS by the time that they reach their forties.

PCOS Project 18
Obesity is present in over 50% of women with PCOS. Insulin resistance and hyperinsulinemia
are common findings in both obese and non-obese women with PCOS. Independently, obesity
also leads to insulin resistance. Therefore, obese women with PCOS have two contributing
factors causing them a greater degree of insulin resistance than non-obese women with PCOS
(Tsilchorozidou, et al., 2004). Endocrine disturbances in PCOS lead to increased blood pressure,
increased low-density lipoprotein (LDL) cholesterol, and decreased high-density lipoprotein
(HDL) cholesterol. These are known significant risk factors for developing cardiovascular
disease and metabolic syndrome (Ehrmann, 2005; Sheehan, 2004). Elevated androgens cause
hirsutism in 60%, acne in 15% to 25%, and androgenic alopecia in an estimated 5% of women
with PCOS. Hirsutism is a most reliable index for elevated androgens. AES states PCOS cannot
be diagnosed without either clinical or biochemical evidence of hyperandrogenism (Azziz, et al.,
2006).
Psychosocial Sequelae
In Snyder‟s (2006) study, women with PCOS recognized themselves as different from
other women without the disease. Higher than average weight gain, lack of regular menstrual
cycles, heavy or continuous bleeding with occasional menses, growth of excessive unwanted
facial and body hair, and severe mood swings were identified as the characteristics that made
PCOS sufferers feel different. They also expressed that feeling different from other women
created a sense of insecurity and isolation (Snyder). The study participants stated that hirsutism
and infertility problems made them feel less feminine as though womanhood had been stolen
(Kitzinger & Wilmot, 2002; Snyder).
Obesity also contributed to a sense of being not normal or not looking like the media
portrayal of femininity (Snyder, 2006). Women with PCOS define a normal female as one who
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looks more female (without hirsutism), possesses a beautiful complexion, and has regular
menstrual cycles (Snyder). A 1998 study by Cronin, et al. of 100 women with PCOS found while
some women were concerned about irregular menses and infertility, weight or hirsutism caused a
greater negative impact on their quality of life.
There is an association between obesity in young girls and PCOS. Childhood obesity may
be the initial symptom of PCOS (ACOG, 2006). Trent, Rich, and Austin (2002) using a health
related quality of life (HRQoL) inventory determined that adolescent girls with PCOS selfreported a statistically significant reduction in general health perceptions, behavior, physical
function, and family activities compared to adolescent girls without PCOS.
Cancer Risks
Endometrial hyperplasia, as well as endometrial, ovarian and breast cancer are associated
with PCOS. The endometrial hyperplasia and cancer are attributed to the continuously estrogen
stimulated endometrium that goes unopposed by progesterone due to anovulation. Endometrial
cancer is also associated with obesity and type 2 diabetes mellitus, which is prevalent in women
with PCOS (Hardiman, Pillay, & Atiomo, 2003). Determining the cause of the increased
prevalence of breast and ovarian cancer is difficult. Obesity, anovulation, and infertility are
independent risk factors associated with breast and ovarian cancer, and they are common
problems in PCOS (Balen, 2001).
Sleep Apnea
An increased prevalence of obstructive sleep apnea that cannot be explained by obesity
alone has been found in women with PCOS. A study by Fogel, Malhotra, Pillar, Pittman, Dunaif,
and White (2001) found that, after controlling for body-mass index (BMI), the risk of sleepdisordered breathing was increased by a factor of 30. Fogel, et al. determined that insulin
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resistance seems to be a stronger predictor of sleep-disordered breathing than age, BMI, or
elevated free testosterone.
Infertility, High Risk Pregnancy, and Potential Delayed Lactogenesis
A common reason why women with PCOS seek care is infertility. Anovulation is a
hallmark of the disorder. Anovulation is due to the increased number and the disturbed
maturation of recruited ovarian follicles resulting from androgen excess, increased LH, and
decreased FSH stimulation of the ovary (Diamanti-Kandarakis, 2008; Diamanti-Kandarakis, et
al., 2006). Women with PCOS who desire pregnancy are usually referred to a gynecologist or
reproductive endocrinologist for infertility treatment. Obesity is a factor that contributes to
infertility. Increasing body mass index (especially >35) yields a decrease in fecundity (Legro,
2007).
There is conflicting evidence about the increased risk of early spontaneous pregnancy
loss in women with PCOS. The role of obesity as a cause of early pregnancy loss is a
confounding, independent risk factor. Early pregnancy loss is associated with hyperinsulinemia,
which is present in both obese and non-obese women with PCOS. It is thought that reduced
insulin sensitivity may cause an endometrial inflammation reaction, which prevents implantation
and leads to early pregnancy loss (Siassakos, & Wardle, 2007).
Antenatal complications associated with PCOS include: impaired glucose tolerance,
gestational diabetes mellitus, pregnancy-induced hypertension, and pre-eclampsia. Iatrogenic
premature births and increased rates of cesarean births are also associated with PCOS (Marx, &
Mehta, 2003; Siassakos, & Wardle, 2007). A postnatal complication for large babies of obese
women is the tendency to become obese adults. There is concern that in utero fetal programming
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of growth hormone and insulin growth factors may influence postnatal growth and insulin
sensitivity of individuals (Siassakos, & Wardle).
Endocrine issues such as polycystic ovary syndrome can affect milk production. Case
studies by lactation consultants report some women with PCOS who have successfully become
pregnant and successfully initiated breast feeding. However, such women are often unable to
produce a sufficient volume of milk to nourish a growing infant (Amir, 2006; Betzold, Hoover,
& Snyder, 2004). Although some women with PCOS have no problem breastfeeding, there
appears to be a group of women with PCOS who have underdeveloped mammary tissue that
cannot produce an adequate milk supply (Marasco, Marmet, & Shell, 2000). Amir noted that the
inability to successfully lactate may be related to hormonal imbalances or increased serum
androgen levels. Elevated androgen levels are associated with decreased breast cell proliferation
and lack of sufficient breast tissue development to maintain milk production. The causes of
delayed or failed lactogenesis II result from one of many endocrine errors or insufficient
mammary tissue (Betzold, et al.; Marasco, et al.).
Opportunities for the Project
The clinical setting in which the project was implemented provided opportunities that
support the initiation of such a project. The clinic offers services to adults who have no insurance
and meet certain income guidelines. The income guidelines are based on family size and living
on a gross salary at or below 150% of the poverty level. This clinic depends on a variety of
physicians and midlevel providers, who receive either minimal reimbursement or who volunteer
their time free of charge, to provide care for this population of patients. Over time, patients do
not see the same provider or group of providers on a consistent basis, so continuity of care is not
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always possible. Despite the limitations of the free clinic, the goal of this clinic is to deliver
quality care for its clients.
The clinic acquired an electronic medical record system from HealtheWV, which includes
electronic note charting and chronic disease templates that remind health care providers to order
required tests to monitor the health status and patient response to therapy. For the proposed
project, the project manager (this author) proposed development of an evidence-based electronic
PCOS patient management and charting template, which could be incorporated into the
electronic system. The goal is for the HealtheWV electronic system to assist providers to provide
consistent, evidence based, high quality care for women with PCOS. It was proposed that when a
diagnosis of PCOS is made, an evidence-based management plan would be generated by the
HealtheWV electronic system, following the same computer generated format used for other
chronic diseases. This computer capability should improve the consistency of management plans
for therapies and required health care surveillances, which are expected to improved outcomes
over a life time for women with PCOS.
Congruence with Organization‟s Strategic Plan
This project encompasses a holistic health care approach to the diagnosis and
management of a serious chronic disorder that affects the health of a significant portion of
women in WV and in the United States as a whole. The PCOS project is compatible with the
mission of the free clinic to improve the health and well being of non-insured, lower income
women in WV through education and health care. The PCOS project focuses on prevention of
negative health sequelae secondary to a chronic health problem for women who lack the
financial resources to obtain this level of health care in the traditional health care system. Women
from Appalachian cultures tend to place the needs of their families before their own health;
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therefore, they are less engaged in preventive health care (Patton, 2005). First line therapy for
PCOS includes life style changes and preventive care that require support from health care
systems (Kovacs, 2006).
Project Description
An in-depth review of the literature relevant to PCOS was completed and the evidencebased recommendations were organized into a diagnostic guide and management plan prior to
implementing the two part project. The first aspect of the project focused on improving the
diagnosis of PCOS at a free primary care clinic. An educational session was conducted during
the quarterly provider staff meeting at the clinic. Accepted definitions used to identify the
diagnostic characteristics and symptoms that are present in women with PCOS were emphasized.
A list of both primary and secondary PCOS symptoms that should prompt the provider to
consider PCOS as a differential diagnosis for women with such symptoms was described. A
brief review of pathophysiology was included to enhance provider understanding of the
complexity of the biochemical interactions and feedback pathways of this endocrine disorder.
Understanding the complex pathophysiology should enhance the provider‟s ability to diagnosis
PCOS early as well as increase his or her understanding of the importance of early intervention.
An evidence-based patient management guide was created and incorporated into the
HealtheWV electronic patient management system for providers to help them manage or prevent
the wide variety of sequelae that can result from PCOS. HealtheWV is an electronic patient
record system that enables chronic illness management plans to be pre-programmed into the
system. When a patient is diagnosed with a chronic illness, the system will prompt the provider
to order selected screening tests specific for the diagnosis. This system also prompts the provider
as to which and when routine health maintenance surveillance tests are due.
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Project objectives
The objectives are:
1. To provide an educational session at a free clinic to increase providers‟ knowledge
about diagnosing PCOS;
2. To assess health care providers' knowledge about PCOS and its management before
and after an educational session;
3. To develop a management plan and imbed the plan in an electronic patient record
system at the free clinic to improve efficiency and quality of care for PCOS
management;
4. To evaluate the effectiveness of an electronic management plan in increasing the
frequency of diagnosis, and appropriateness of treatment of PCOS at the free clinic.
Project Design
Timeline
The project was initiated in August 2008 and continued through 2009. For a step-by-step
timeline please see Appendix A.
Resources
There is minimal expense to the free clinic. HealtheWV system has templates for other
common chronic illnesses currently in place. The electronic charting system is a recent
acquisition of the clinic. By designing the PCOS template at this time, no technician salary cost
will be incurred to assist the project manager in loading the data and creating the pathways that
signal the care provider as to which tests to order if indicated for the diagnosis, and when
recommended health screenings are due.
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Cost savings for patients and the health care clinic will require a cost analysis to
determine savings created by decreased expenditures arising from sequelae and/or
hospitalizations for problems that can be avoided through timely diagnosis and appropriate
management of PCOS. However, the cost analysis should not be performed until the project has
been implemented for an extended period of time that will be determined. Cost analysis will not
be a part of this project. Patient care satisfaction for women with this disease is anticipated to
improve, as they perceive a health care system that is responsive to the specific issues associated
with PCOS.
Budget
The budget to implement the PCOS project is included in Appendix B.
Evaluation
PCOS is a women‟s health issue that is currently under diagnosed. When PCOS is
diagnosed, consistency in initiating management and recommending surveillance plans for
secondary prevention of the complications of PCOS often does not occur. A consistent evidencebased plan is essential to delay or prevent the multiple health problems that can occur in women
with PCOS. It is essential for the health of this group of women that efforts are made to improve
the diagnosis and management of this chronic endocrine disorder.
In association with an educational session, both a pre- and posttest knowledge assessment
about diagnostic criteria and laboratory testing were completed with providers at the free clinic
(Appendix C). Such testing indicated whether learning had taken place and can serve as
indicator about the effectiveness of the education strategy. The clinic at which the project was
conducted has quarterly provider meetings. The agenda for the provider meetings includes a time
slot for continuing education. The PCOS educational session was presented at the May meeting.
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A PowerPoint presentation along with a question and answer opportunity was offered (Appendix
D).
To assess their prior knowledge about PCOS, a tool developed by this author was
completed by the providers. After providing an educational session that included a question and
answer session, the same tool was used to determine if providers‟ knowledge had improved.
Knowledge acquisition was assessed by using a matched sample t-test to compare the difference
in means between the two sets of test scores.
A PCOS management template was developed by the Project Director (Appendix E) and
incorporated into the clinic‟s electronic patient data system to be utilized by providers. A chart
review was conducted before the template was made available and again 3 months after the
PCOS management template was loaded into the HealtheWV electronic patient management
system. The chart review was intended to determine whether providers evaluate patients who
present with abnormal menstrual cycles and/or clinical or biochemical symptoms of excess
androgen for PCOS using the appropriate laboratory testing. The chart review noted whether an
evidence-based plan was initiated at the time of diagnosis prior to the initiation of the electronic
plan. Successful use of the electronic PCOS management plan for this project was defined by
30% or more of the patients diagnosed with PCOS having a management plan initiated in the
HealtheWV system.
Three months after the education session, 50 charts of women presenting with abnormal
menstrual cycles and/or clinical or biochemical symptoms of excess androgen were evaluated
using the same criteria as the pre-intervention chart review. The post intervention chart review
also added the question: Is the electronic PCOS management initiated.
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Results
Objective 1.
The first objective was to provide an educational session. This objective was met on May
14, 2009. An educational information session (Appendix D) about diagnosis and long-term
management of the health care of women with PCOS was presented at the provider staff
meeting.
Objective 2.
Assessment of health care providers‟ knowledge about diagnosing and managing PCOS
was the second objective. To measure the initial knowledge level and a change in knowledge
after education, a pre-test and post test (Appendix C) were completed by each participant. The
test consisted of five questions developed by the author. The questions were designed to evaluate
the five learning objectives for the education session. The test questions were evaluated for
clarity and correct content by an expert in women‟s health. The objectives for the educational
session were:
1) The participant will be able to state the diagnostic criteria for PCOS,
2) The participant will be able to identify other causes of excess androgen that must be
excluded,
3) The participant will be able to identify initial laboratory tests for diagnosis and
4) The participant will be able to name the risks associated with PCOS.
Because of the varying schedules and infrequency of providing services to patients at the
clinic by some of the providers, the participants were asked to complete the pre and post test
before and immediately after the session. Participants were asked not to provide any identifying
information on the tests. Ten participants completed the pretest and demonstrated a mean
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knowledge score of 1.5 on a scale with a range of 0 to 5(O = lower and 5 = higher). Eight
participants completed the post test with a mean score of 4.25. Two providers at the session
chose not to participate. Due to the small sample size, a Mann-Whitney test was used to
determine whether there was a change in knowledge before and after the educational session. A
significant change in knowledge (p = .000) occurred as a result of the educational session. (See
tables 1, Appendix E and table 2, Appendix F)
To assess specific areas of knowledge deficit the number of correct answers to each
specific question on the pretest was calculated. The range of questions answered correctly was
zero to three out of five total questions. Acknowledge deficit about PCOS existed for this group
of providers. No provider was able to identify the three diagnostic criteria for PCOS. After the
session, seven of eight (87.5%) of providers correctly identified the three diagnostic criteria. At
the pretest, one provider, out of 10 (10%) identified other causes of hyperandrogenemia that
must be excluded; and six of eight (75%) at the post test could correctly identify other causes.
Two providers out of 10 (20%) identified the recommended diagnostic laboratory tests prior to
the educational session, and six out of eight (75%) correctly identified the correct laboratory tests
after the educational session. Five providers of 10 (50%) could identify the potential risks
associated with PCOS prior to the educational session and eight of eight (100%) identified the
risk factors correctly after the educational session. The first line therapy of choice was correctly
identified by seven out of 10 providers (70%) prior to the session, and seven out of eight (87.5%)
after the educational session. Improvement in knowledge levels in the five areas identified by the
learning objectives resulted from the educational session. (See figure 1, Appendix G)
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Objective 3.
Due to limitations in current technology, an electronic provider prompt to consider
PCOS as a differential diagnosis when symptoms are entered into the e-chart was not able to be
embedded into the system. Due to software restrictions, a modified template (Appendix H), with
a recommended health management plan for this chronic disease was created as part of the
clinic‟s electronic charting system.
Objective 4.
To evaluate the effectiveness of an electronic management plan in increasing the
frequency of diagnosis, and appropriateness of treatment of PCOS at the free clinic a pre and
post chart review was completed. Five hundred and thirty- five charts of women cared for by the
eight providers who agreed to participate in the study were reviewed for inclusion criteria. The
inclusion criteria were patient charts with documented amenorrhea, abnormal menstrual cycles or
abnormal or dysfunctional uterine bleeding, and with clinical symptoms of excess androgens.
These clinical symptoms included hirsutism, acne, or alopecia. Thirty-four charts were found to
meet the inclusion criteria. Since PCOS affects 5-10% of women of reproductive age, 34 out of
the 535 charts meeting the criteria for inclusion represented an appropriate sample.
For data collection, two questions were posed. The first question posed was „Are the
appropriate diagnostic laboratory tests ordered?‟ The response was either yes or no. The criteria for
a yes response for charts prior to the educational session included women who had a diagnosis of
PCOS prior to admission to the clinic system, and those who had been diagnosed with PCOS using
the conventional diagnostic testing that was the standard of care at the time of diagnosis.
Conventional diagnostic testing include: lutenizing hormone levels, follicle stimulating hormone
levels, thyroid stimulating hormone levels, total testosterone levels, fasting glucose levels, and an
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insulin level. Evidence-based studies currently recommend a prolactin level, thyroid stimulating
hormone level, total testosterone levels, and 17 hydroxyprogesterone level for initial diagnostic
testing, and further studies can be added if indicated by the results of the initial findings. Of the 34
total charts, 31 charts met the criteria for inclusion prior to the educational session and three new
charts entered the system after the educational session.
Three months after the educational session a chart review, using the same two questions
was conducted to determine whether appropriate diagnostic laboratory testing was ordered when
undiagnosed women presented with symptoms suggesting PCOS, as well as to determine if
appropriate screenings were ordered for women already diagnosed with PCOS. Post education, 23
charts were available for review. Eleven of the 31 pre-educational charts were lost to follow up
and three new charts entered the system. The 23 eligible charts were then further reviewed for
documentation by the providers specifically noting if the appropriate diagnostic laboratory
assessments, if indicated, had been ordered, and if the appropriate metabolic screening tests were
obtained if they had not been performed within the year. The same questions were used to select
charts for the post-educational review as had been posed in the pre- education chart review.
1) Were the appropriate diagnostic laboratory assessments performed when women presented
with abnormal menstrual cycles and a clinical sign of excess androgen? (yes or no) 2) Were
appropriate metabolic screen testing obtained if PCOS was diagnosed? (yes or no)
Post educational session, the question about appropriate metabolic screen testing was answered
yes if four studies, prolactin level, thyroid stimulating hormone level, total testosterone level, and
17 hydroxyprogesterone level were ordered, or the diagnosis of PCOS was made prior to the
educational session (n = 23). If the diagnosis PCOS had been made prior to the educational
session, one would not expect a second set of diagnostic laboratory tests to be ordered to
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diagnose PCOS again so those charts received a yes for appropriate diagnostic laboratory testing.
Prior to the provider‟s educational session appropriate testing for diagnosis was found in 10 of
31 cases (32.3% of the time). Post educational session appropriate diagnostic testing was found
in 16 of 23 cases (69.6% of the time). (See table 3, Appendix I and figure 2, Appendix J)
Flow Chart for Patient Chart Selection

For the 20 cases present before and after the education session, a Pearson Chi-square was
use to determine if there was a significant difference in providers ordering appropriate diagnostic
tests three months after the educational session. A Chi-square test for independence indicated no
significant difference in pre and post educational session for ordering appropriate diagnostic
tests, X2 (1, N = 20) = .73, p = .143.
Prior to the educational session appropriate metabolic screening tests used as part of a
chronic management plan were ordered in 20 of 31 cases (64.5%) and post educational session
such tests were ordered 19 of 23 (82.6% ) times. (See table 4, Appendix K and Figure 3,
Appendix L).
For the 20 cases evaluated before and after the education session, a Pearson Chi-square
was use to determine if there was a significant difference in providers ordering appropriate
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metabolic screening tests three months after the educational session. A Chi-square test for
independence indicated no significant difference in pre and post educational session for ordering
appropriate metabolic screening tests, X2 (1, N = 20) = .000, p = 1.000.
Of the three new cases that presented with symptoms of PCOS, two had the appropriate
diagnostic and metabolic screenings ordered by the provider. The third woman was referred to
the women‟s health clinic within two weeks of her new patient visit for evaluation at the clinic.
Discussion
Discussion of the project
The Chronic Care Model served as the guide for this project. The model blends
the community resources and policies with the organization of the health care system to improve
patient outcomes. This project focused on the health care system‟s concept, and specifically the
clinical information system‟s element. It is essential for the practice team to be prepared and
proactive in the management of a chronic illness. In a busy clinic, utilization of technology and
clinical information systems is especially efficacious when a team of providers cares for
chronically ill patients. The use of electronic templates, which can provide care reminders, aids
the healthcare team in providing timely and consistent care for a patient without relying on the
memory of both the patient and the provider to follow a plan. The clinic, in which this project
was staged, operates by using a team of primary care providers. The use of the electronic
charting system has the potential to keep the team prepared and proactive in the care of women
with PCOS. However the limited technology of the computer charting system and the inability
to have the appropriate prompts for PCOS embedded does not assist the provider to remain
proactive. This project does not support CCM being effective at this time.
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Discussion of the findings
Objective1.
Twelve providers attended the quarterly provider meeting, which occurred as scheduled.
Of the twelve providers present eight consistently provide primary care for women who attend
the clinic. A discussion including questions and answers by participants occurred during and after
the power point presentation. The eight providers who regularly manage the health care of
women are included in the evaluation data. Three of the excluded members are sub-specialist and
do not provide primary health care. The fourth excluded practitioner is new to the clinic and had
not begun caring for patients until after initiation of the project.
Objective 2.
The decision to require the group to complete the post test immediately after the session
was due to the dynamics of the group. The providers practice on a limited, part- time basis, from
four hours per month to 8 hours per week, and on different days. It was determined that few
providers would complete the post education questionnaire if the testing was not requested
immediately after the education session because of the sporadic and part- time schedules of this
groups of providers. Loss of data post-educational session with this small number of providers
would affect the findings. Specifically for this reason, providers‟ knowledge was not tested again
several months after the educational session. Testing of knowledge about PCOS at three or six
months after the educational session would possibly show a no significant change from prior to
the initial educations session due to the natural loss of knowledge over time (Davis, et al.1995).
Since PCOS is a common women‟s health problem, one can assume that this group of
providers had obtained baseline knowledge about PCOS during their professional education.
Yet, the provider‟s mean test score on the pretest was low and showed a significant
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improvement after the educational session indicating that their knowledge about evidence- based
care for diagnosing and managing PCOS was deficient. Studies by Davis, et al. (1995) and
Guradini, et al.(2008) support the need for refresher courses for providers to alleviate errors,
which occur due to decrease in vigilance or memory, and/or lack of knowledge by providers. The
educational session significantly improved the health care providers' knowledge about PCOS and
its management. Refresher courses or continuing education sessions are required to prevent
natural loss that occurs over time (Davis, et al.; Guradini, et al.) and should be offered at regular
intervals.
Although testing was not performed to assess whether long term the knowledge about
PCOS was retained, it is a positive finding that three new patients, with symptoms, who entered
the system after the educational session, were either appropriately managed or were referred by
the primary care provider to a woman‟s health provider to be evaluated for PCOS.
Diagnostic criteria and laboratory testing that is required to make a diagnosis of PCOS
were the two areas of greatest knowledge deficit. A predominant reason missed diagnoses occur
and there is a failure to create a long-term management plan is failure on the part of the provider
to order appropriate diagnostic tests (Gandhi et al., 2006; Singh et al., 2007). Provider
knowledge deficit and forgetfulness over time were identified by Gandhi et al. (2006) as major
contributors to failure to order appropriate diagnostic testing. These studies support the finding
that the greatest area of knowledge deficit for this group of providers is identification of
diagnostic criteria and laboratory testing. Provider reminders were identified as an effective
single-method producing effective practice change (Davis, et al., 1995). This new electronic
system did not possess the technology necessary to provide a “pop-up” electronic prompt that
would suggest differential diagnoses and diagnostic protocols when symptoms are entered into
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the e-chart. Because the Healthe WV system could not provide diagnostic criteria, a guide to
laboratory blood tests for diagnosis with the diagnostic values, and the recommended laboratoryscreening schedule was given to each provider participant as a laminated, pocket size card
containing the information. Prior to the educational session, providers did know that the first line
management for PCOS is lifestyle changes. Documentation of lifestyle changes is part of the
selection menu in the plan section of the electronic chart that is used for each visit.
Objective 3.
An objective was to develop a management plan and imbed the plan in an electronic
patient record system at the free clinic. Prior to starting the project, a discussion was held with
the software developers of the electronic charting system about the possibility of developing a
template for incorporating clinical decision making support, appropriate testing for diagnosis and
appropriate follow-up. Both the software company and the clinic granted temporary
administrative status to this author so the template for chronic management could be designed
based on the current capability of this system (Appendix E).
Computer technicians designed the basic electronic patient record template with basic
knowledge about the standard structure universally used to create a patient visit note. These
developers were not health care or content experts. While this system is designed to allow for the
development of templates that indicate the management for chronic illnesses, it does not have the
capability to organize patient data into clinical algorithms, or suggest differential diagnoses for a
set of signs and symptoms. Nor does this system allow for variations required to individualize a
patient care plan from a standard care plan. Perhaps this is due to the limitations with current
technology or the failure of software developers to understand and respond to this type of
provider need in a busy clinic. The CCM has delivery system design, decision support, and
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clinical information systems as three of the six elements that are necessary in a health system to
create a prepared proactive practice team, which lead to improved patient outcomes (McCulloch,
et al., 1998; Von Korff, et al., 1997; Wagner, et al., 1996a; Wagner, et al. 1966b). Use of an
electronic system that is sophisticated enough to suggest differential diagnoses based on
symptoms could decrease missed or delayed diagnoses that occur from failures in judgment,
cognitive errors due to dependence on memory, or lack of provider knowledge (Gandhi et al.,
2006).
In designing the note template, selection of characteristics for the patient review of
systems section and physical findings for the examination section were limited. Each e-chart
section provides a choice of “other” and a pencil icon so the provider can type in any finding that
is not on a drop down menu. There was not an option of adding the Ferriman and Gallwey
hirsutism scale (Wild, Vesely, Beebe, Whitsett & Owen, 2005). However, hirsutism, which was
not on the general template prior to the project, was added as a selection on the drop down menu
in the endocrine section of the review of systems. In the skin section of the physical exam area,
the provider is able to select a face and body image on which areas can be identified with a typed
in description of the finding from the physical examination.
The basic templates provided in HealtheWV do include appropriate screening intervals
based on the U.S. Preventive Services Task Force (USPSTF) (2009) or other expert panel‟s
recommendations for the population at large, and prompts for providers, which indicate that a
surveillance screen or monitoring test is due. When development of the PCOS template began, it
became evident that screening interval prompts in the e-chart could not be changed from the
interval set by USPSTF for the general population to an appropriate interval for patients at high
risk for developing a disease, or for chronic management if the specific disease existed. For
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example, screening intervals for lipid panels in the system are those recommended by USPSTF
(2009) for a person who is not at risk and with normal values at their most recent screening.
While frequency guidelines for lipid screening for women with PCOS are not specified, these
women are at a greater risk for developing dyslipidemia. The software does not permit changes
in the template to prompt providers to screen at closer intervals that should be considered for
women with PCOS. While this does not prohibit the provider from ordering a surveillance test at
a closer interval, a more frequent prompt option for the provider is not available. Without the
closer interval prompts, screening is now dependent on the memory of the provider. The study by
Gandhi et al. (2006) recommends changing systems to alleviate cognitive errors by reducing
dependence on memory for appropriate testing and clinical diagnosis. Errors associated with
follow-up and further evaluation can be decreased by forcing consideration of evidence-based
diagnostic plans (Gandhi et al.). Perhaps as technology develops further the template can be
adjusted to initiate closer interval prompts for patients at higher risk. A systematic review by
Davis, Thomson, Oxman, and Haynes (1995) found that a simple reminder system is an effective
single-method intervention to improve provider performance for clinical care.
The CCM upon which this project was designed, states that improved outcomes for
people with chronic illnesses depend on productive interaction between informed patient and
prepared proactive provider team. Having a template that prompts providers about the ongoing
plan of care helps them to remain proactive. By sharing the plan of care with the patient, the
patient becomes informed and can become self-directing in managing his or her health plan.
Objective 4
Although a management template for PCOS exists in Healthe WV system, the clinic
system‟s current method of template selection for a patient visit does not allow the provider to
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select a specific template for charting. As patients arrive for a health care visit, they are
registered and then initially evaluated by a medical assistant. Thus the medical assistant is the
person who selects the note template when commencing the visit note, not the provider. The
medical assistant may not be aware of the diagnosis or purpose of the visit unless the patient tells
them. Often the purpose of the visit or a diagnosis may change after further patient evaluation by
a provider. It is not a simple task to change the template during the visit after the management
template is initiated by the medical assistant. The patient‟s vital signs and any notes made by the
nursing staff do not automatically appear in a new template window if a different template is
selected later. Thus, the PCOS template often was not selected.
This project proposed to evaluate selection and use of the PCOS template three months
after the educational session. The option for the provider to select the template was not feasible
in the clinic setting. The purpose of the template was to create an electronic reminder system for
providers with the goal of improving the appropriate diagnosis and management of women with
PCOS. To assess whether improvement in diagnosis and management after the educational
session occurred, a chart review to assess ordering of appropriate laboratory testing for diagnosis
and metabolic screening for development of a management plan was conducted. Currently,
whether the provider orders a diagnostic evaluation for women who present with symptoms
suggesting PCOS remains dependent on the provider‟s knowledge.
The second question posed was “Are the appropriate metabolic screens being ordered?”
The response was either yes or no. A yes response at either pre or post educational session was
selected if the provider ordered a lipid panel, and a fasting glucose or hemoglobin A1C at either
that visit, at the flowing visit, or if those tests had been ordered within the year. Prior to the
educational session 64.5 % of the patients had both glucose and lipid levels evaluated and after
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the educational session 82.6 % had this evaluation completed. No statistical difference for
frequency of metabolic laboratory testing was found between the pre and post educational
session. Lack of a significant difference between screening for a metabolic disease before and
after the educational session was expected because 12 cases prior to the educational session had
co-morbid conditions that also require glucose and lipid level monitoring.
As a result of this project the primary care providers are more aware of associating the
combination of abnormal menstrual patterns and symptoms of excess androgens with the
underlying cause of PCOS. Thus a more holistic approach to PCOS management can occur
instead of treating the symptoms only. The holistic approach fosters the delay or prevention of
the long term health problems that are part of the disease process.
Selection of hirsutism has been added to the general e-template and the provider no
longer is required to type this in the chart. By having the selection of “hirsutism”, each time a
provider charts it acts as a prompt and increases their awareness that abnormal hair patterns in
women are an indicator of an endocrine disorder that must be investigated. The results of this
project support that education improves provider knowledge. The data does not support that the
HealtheWV electronic charting system improves the quality of health care given to PCOS
population at this clinic. Further long term studies are required to assess whether health
outcomes for women with PCOS improve as a result of electronic charting.
Recommendations
Technology and the use of electronic patient records is now a necessary part of most
health systems. Technology can be a helpful tool for providers that can improve health care
delivery. As electronic systems improve with advancing technology, nurses need to be involved
with the design. Nurses can bring evidence- based care recommendations for patient care plans
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into charting systems. Nurses can provide knowledge about, not only the disease but also the
function of the health care system to technicians who design the systems, so that electronic
charting systems become easier to use and are helpful to providers caring for chronically ill
patients including women with PCOS. A user friendly system is more likely to be utilized by
providers to the fullest capacity for which the technology is designed. Providers will more
readily rely on an evidence-based, user friendly tool as an aid to keep them informed and
proactive in the care of women with PCOS.
Nurse practitioners and other providers who care for women must be more vigilant about
recognizing signs and symptoms of PCOS. Nurse practitioners have the potential to develop
national professional meetings and workshops. Such professional educational forums should be
encouraged to include content that focuses on PCOS. Nurses who practice at the highest level
and implement practice changes based on evidence from research should educate providers
through workshops, publications and clinical practice as they care for women who live with
PCOS every day.
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Appendix A
Timeline
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Timeline
Objective
Step 1
·
·
·
·
·

Synthesize and organize the current science
Write learning objectives for the education session
Write the content of the education session
Write the pre and post-test
Implement the education session

Step 2
· Work with the technicians at HealtheWV to develop the
management plan template
· Chart Review to determine percentage of PCOS plans
that are initiated at time of diagnosis in the electronic
system occurs
Step 3
· Analyze the impact of the project by:
1)
Measuring the difference in the mean test scores on the
pre and post test given to providers who attend the session.
2)
Determining the percentage providers initiating the
electronic PCOS care plans initiated by the provider

Time Line
August 10, 2008
August 10, 2008
August 10, 2008
August 10, 2008
September, 2008

December 15, 2008
August 15, 2009

December15, 2009

PCOS Project 51

Appendix B
Budget
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PCOS Capstone Project
Proposed Budget
Personnel
My time
Secretary support
IT technician time (HealtheWV)
Supplies
Paper $10.39/ream
Ink
$30.00/per cartridge

My Cost
$
$
$

0
0
0

$
$

10.39
60.00

Overhead Expense
Telephone expense
Donated by SON
Office space
Donated by SON
Library Fee if Ind. Project
HSC Fee paid
Source of the cost of supplies is based on Office Depot web site and costs in 2008.
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Appendix C
Pretest-Posttest
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Pre-Test for PCOS Provider Education Session
1. What are the three diagnostic criteria for PCOS based on the 1991 NIH Conference
and the Androgen Excess Society in 2006?
A. Polycystic ovaries, insulin resistance, clinical or lab findings of
Hyperandrogenism
B. Chronic anovulation, clinical or lab findings of hyperandrogenism, exclusion of other
causes of hyperandrogenism
C. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, polycystic ovaries
D. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, insulin resistance
2. All of the following are other causes of hyperandrogenemia EXCEPT:
A. Cushing‟s Syndrome
B. Non-classical congenital hyperplasia
C. Abnormal LH:FSH ratio
D. Acromegaly
3. Which of the following groups are the recommended diagnostic laboratory studies to order?
A. Total testosterone, 17-hydroxyprogesterone, Prolactin level, TSH
B. Total testosterone, 17-hydroxyprogesterone, LH, FSH
C. Total testosterone, LH, FSH, Insulin level
E. Total testosterone, Pelvic U/S of the ovaries, Fasting blood sugar, Insulin level
4. Women with PCOS are at risk of developing the all of following EXCEPT:
A.

Sleep Apnea

B.

Ovarian cancer

C.

Metabolic syndrome

D.

Hyperthyroidism
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5. The management plan for women with PCOS should begin with:
A.

Lab screenings for insulin resistance and begin metformin if indicated

B.

Life-style changes

C.

Prescribe oral contraceptive to protect the uterine lining

D.

A pelvic ultrasound to look for cystic ovaries and endometrial stripe size
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Post Test for PCOS Provider Education Session
1. What are the three diagnostic criteria for PCOS based on the 1991 NIH Conference
and the Androgen Excess Society in 2006?
A. Polycystic ovaries, insulin resistance, clinical or lab findings of
a. Hyperandrogenism
B. Chronic anovulation, clinical or lab findings of hyperandrogenism, exclusion of other
causes of hyperandrogenism
C. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, polycystic ovaries
D. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, insulin resistance
2. All of the following are other causes of hyperandrogenemia EXCEPT:
A. Cushing‟s Syndrome
B. Non-classical congenital hyperplasia
C. Abnormal LH:FSH ratio
D. Acromegaly
3. Which of the following groups are the recommended diagnostic laboratory studies to order?
A. Total testosterone, 17-hydroxyprogesterone, Prolactin level, TSH
B. Total testosterone, 17-hydroxyprogesterone, LH, FSH
C. Total testosterone, LH, FSH, Insulin level
D. Total testosterone, Pelvic U/S of the ovaries, Fasting blood sugar, Insulin level
4. Women with PCOS are at risk of developing the all of following EXCEPT:
A. Sleep Apnea
B. Ovarian cancer
C. Metabolic syndrome
D. Hyperthyroidism
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5. The management plan for women with PCOS should begin with:
A. Lab screenings for insulin resistance and begin metformin if indicated
B. Life-style changes
C. Prescribe oral contraceptive to protect the uterine lining
D. A pelvic ultrasound to look for cystic ovaries and endometrial stripe size

PCOS Project 58

Appendix D
Educational Session PowerPoint Slides
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Elizabeth DuRant, WHNP-BC, CNM

Purpose of Presentation
 Brief educational unit on PCOS to introduce a
management plan that will be found as a chronic
illness template in HealtheWV

1
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At the end of the session the participant:
 Will be able to state the diagnostic criteria for PCOS
 Identify other causes of excess androgen that must be

excluded
 Identify initial laboratory tests for diagnosis
 Be able to name the risks associated with PCOS
3

A typical clinical presentation
 Irregular or absent menstrual cycle
 Episodes of prolong heavy vaginal bleeding

&
 Hirsutism and/or Acne
or
 Inability to conceive

4
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Diagnostic Criteria
NIH 1991 Conference

Rotterdam Consensus
2003 (2 of 3)

Androgen Excess Society
(AES) 2006

Chronic anovulation

Oligo-and/or anovulation

Oligo or anovulation &/or
polycystic ovaries

Clinical signs or androgen
excess &/or
Elevated Testosterone
Levels

Clinical signs &/or
Elevated testosterone
Levels

Clinical signs of androgen
excess &/or
Elevated Testosterone Levels

Exclusion of other causes

Polycystic ovaries*

Exclusion of other causes

Rotterdam Consensus 2003 also includes exclusion of other causes as part of the diagnostic criteria.

* Polycystic ovaries are defined as having at least 12 or more follicles measuring between two to
nine millimeters in diameter or an enlarged ovarian volume of greater than 10 millimeters cubed
(Balen, Laven, Tan, 2003).
5

Which one to follow?
 ACOG follows the NIH & AES definitions. (ACOG,
2007).
 The Women’s Health Certificate Program, and Internal
Medicine use the Rotterdam Criteria

6
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Differential and Similar Clinical Features
Condition

Signs of excess
androgen

Oligo or
amenorrhea

Clinical Differential
features

*Non-classical
Congenital adrenal
hyperplasia

Yes

Usually but
may have
regular cycles

Fam Hx of infertility,
hirsutism or both;
Ashkenazi Jewish
Ancestry

Cushing’s
Syndrome

Yes

Yes

HTN, striae, easy
bruising, upper body
obesity with thin
extremities, round
face, thick neck

Hyperprolactinemia

None or Mild
(↑DHEAS)

Yes

Galactorrhea

Primary
Hypothyroidism

None or Mild

May be present

Goiter maybe
present
7

Differential and Similar Clinical Features
Condition
Acromegaly

Premature ovarian
failure

Signs of excess
androgen
None or Mild

Oligo or
amenorrhea

Clinical Differential
features

Usually

Enlarged arms,
hands, fingers, legs,
ears w/ course
features,
Prognathism

None

Yes

Associated w/
autoimmune
endocrinopathies

Simple Obesity

May be

Possible, not
often

Dx of exclusion of
other causes

Virilizing adrenal
or ovarian
neoplasm

Yes

Yes

Often

Possible

Drug-related

Clitoromegaly,
extreme hirsutism or
male-pattern
alopecia
Evidence by Hx

8
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What to order for Dx
 Total testosterone
 17-hydroxyprogesterone (17-OHP)
 Prolactin level

 Thyroid Stimulating Hormone (TSH)

9

Other potential Dx Labs
 DHEAS if testosterone is extremely elevated
suggesting an androgen secreting adrenal tumor.
 If 17-OHP is > 200 ng/dl then refer for an ACTH level.
When 17-OHP > than 800 ng/dl then a diagnosis of
CAH may be made.

10
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Secondary Causes of Hyperandrogenism & Diagnostic Lab
Findings
Disease
Lab findings
Dx values
•Pituitary Tumor

•Elevated prolactin

150 ng/ml

•Adrenal tumors

•Elevated DHEA/DHEAS

700 ng/dl

•Ovarian tumors

•Elevated testosterone

150 ng/dl

•Non-classic CAH

•Elevated 17-OH progesterone

800 ng/dl

•Hypercortisolism

•24 hr urine collection level of
cortisol

 100 mcg/
24hr specimen

Buccola & Reynolds. (2003). Polycystic Ovarian Syndrome: a review for primary providers. Primary Care:
Clinics in Office Practice 30(4)

11

Optional testing to consider
 Ultrasound evaluation of the pelvis for

baseline evaluation and assessment of
sudden onset of excess androgen
symptoms.
 Gonadotrophin levels if evaluating causes

of amenorrhea.
12
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Health Risks Associated w/ PCOS

1.
2.
3.
4.
5.
6.

Metabolic disorders
Central obesity - waist to hip ratio > 0.72
HTN
Dyslipidemia
Nonalcoholic fatty liver
Coronary calcifications
Abnormal C-reactive protein

14

Health Risks Associated w/ PCOS


4.

Reproductive System Cancers
Endometrial hyperplasia
Endometrial cancer
Ovarian cancer
Breast cancer



Most likely due to years of unopposed estrogen

1.
2.

3.

15
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Health Risks Associated w/ PCOS
 Sleep Apnea

Despite BMI women with PCOS have a 30 fold
increase in the incidence of sleep apnea
 Depression
 Infertility

16

Labs to monitor health status
 2 hr Oral Glucose Tolerance Test

Fasting B/S often miss IR PCOS
Optimal screening interval is not known < every 3
years in high risk persons.
 Lipid panel - Optimal interval for screening is

uncertain. Decisions should take into account
overall risk of heart disease
17
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Screenings to Detect Cancer
 Endometrial Cancer

No effective screening method
Endometrial Bx for abnormal bleeding
TV/US or trans-abdominal
US cannot Dx but can provide information to
aid in Dx

18

Screenings to Detect Cancer
 Ovarian Cancer

No effective screening method
Maintain a high degree of suspicion and monitor
for Sx (bloating, early satiety, sudden abd. girth
increase)
 Breast Cancer

Annual CBE
Mammography* every 1-2 yrs beginning at age 40
or with abnormal CBE findings
*BCCSP – Age 50

19
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Management of PCOS
 Early recognition can delay or prevent complications
 Depends on the presenting signs and symptoms
 Lifestyle modification is 1st line treatment

20

Management of PCOS
 Hirsutism & Acne – COCP,
Spironolactone, Mechanical hair removal


Treat the unopposed estrogen state with an OCP or
DMPA. Yaz® is the OCP of first choice. If not
available select a pill w/ low or nonandrogenic
progesterone effects.

21
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Management of PCOS
 Abnormal Menstrual Pattern –

1. Cyclic progesterone or COCP

2. Without hormone therapy - regular

ultrasound to monitor endometrial
thickness

22

Management of PCOS
 Screen for signs of metabolic syndrome – Metformin?
 Screen for and order a sleep study if symptoms

indicate a need.
 Screen for depression at each visit

23
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Follow Up
 Depends on individual signs, symptoms, & treatment
plan
 Every 6 months for abnormal B/P, fasting glucose, and

lipids
 Every 3-6 months initially for anti-androgen therapy
 Yearly CBE, pelvic exam and mammogram if indicated.

24

HEALTHeWV
 Following the other HeatheWV electronic chronic
care models, a model for the management is being
developed and will be available.
 ? Questions ?

25
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With Women for a Lifetime

Thank YOU
For listening
26
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Appendix E
Table 1 Test Scores from Educational Session
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Table 1 Test Scores from Educational Session
N
Mean
Minimum
Maximum

Pretest
10
1.50
0
3

Post test
8
4.25
3
5
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Appendix F
Table 2 Educational Session Test Statistics
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Table 2 Educational Session Test Statistics
Mann-Whitney U
Wilcoxon W
Z
Asymp.Sig. (2-tailed)
Exact Sig, {2* (1-tailed Sig,)]

.500
55.500
-3.579
.000
.000
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Appendix G
Figure 1 Questions Answered Correctly
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Figure 1 Questions answered correctly

Questions Answered Correctly

Percent correct

120
100
80

Pretest

60

Post test

40
20
0
1

2

3
Question

4

5
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Appendix H
PCOS Template
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Appendix I
Table 3 Appropriate Diagnostic Testing
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Table 3 Appropriate Diagnostic Testing
Pre Education Cases with
Appropriate Diagnostic Labs
Post Education Cases with
Appropriate Diagnostic Labs

N
10 of 31

Percent
32.3

16 of 23

69.6
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Appendix J
Figure 2 Percentage of Appropriate Diagnostic Laboratory Tests Ordered
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Figure 2 Percentage of Appropriate Diagnostic Laboratory Tests Ordered
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Appendix K
Table 4 Appropriate Metabolic Screening Tests
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Table 4 Appropriate Metabolic Screening Tests
Pre Education Cases with
Appropriate Metabolic Screenings
Post Education Cases with
Appropriate Metabolic Screenings

N
20 of 31

Percent
64.5

19 of 23

82.6

PCOS Project 86

Appendix L
Figure 3 Appropriate Metabolic Screening Tests
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Figure 3 Appropriate Metabolic Screening Tests

Metabolic Screening Tests
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